Controversy Looms Over Cost Of Unique Drug To Prevent Premature Birth
Federal health officials announced last week that they would not stop pharmacies from making a cheaper alternative to a costly drug given to prevent premature birth.
kv pharmaceuticals
FDA, Clinical Trial News: $ABIO, $GENZ, $KV-A, $SLXP
Shares of ARCA Biopharma (NASDAQ:ABIO) are soaring today on news of an issued patent that includes the methods of treating heart failure patients with Gencaro (bucindolol) based on genetic testing.